Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | +8.39% |
|
+2.31% | -5.68% |
Jun. 07 | Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing | MT |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.68% | 2.21B | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+2.68% | 22.58B | |
-14.57% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Berenberg Bank Adjusts Recursion Pharmaceuticals Price Target to $35 From $33, Maintains Buy Rating